XOMA Corporation (XOMA) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 1 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
amazinite amazinite 03/05/2014 3 months $6.82 $4.30 -37.02% -37 Active
Comments: Exaggerated Correction.
Kreuz55 Kreuz55 10/01/2013 3 months $4.98 $6.91 +38.76% 38 Ended
Comments:
khalid obeid khalid obeid 12/31/2010 1 Year $5.24 $3.53 -32.63% -32 Ended
Comments: Industry sector growing or poised for growth
Bing_1 Bing_1 08/03/2010 3 months N/A Ended
Comments:
Monica_3 Monica_3 05/25/2010 3 months N/A Ended
Comments: excelente
MoMoney_1 MoMoney_1 02/23/2010 3 months N/A Ended
Comments:
yumatiger yumatiger 02/09/2010 3 months N/A Ended
Comments:
mbmalone mbmalone 02/01/2010 3 months N/A Ended
Comments: It is the innovation that will provide the drugs we have out there in the future. XOMA has specialty phage display libraries they use to create and manufacture human antibodies. it's a buyout target.
Nasdaqczar Nasdaqczar 01/26/2010 3 months N/A Ended
Comments: Xoma is a winner. XOMA owns key antibody patents and has a strong product pipeline. XOMA is worth North of $5 a share.

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.